- Home
- ALLE vs SNN Comparison
ALLE vs SNN Comparison
Compare ALLE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- SNN
- Stock Information
- Founded
- ALLE 2013
- SNN 1856
- Country
- ALLE Ireland
- SNN United Kingdom
- Employees
- ALLE N/A
- SNN N/A
- Industry
- ALLE Diversified Commercial Services
- SNN Industrial Specialties
- Sector
- ALLE Consumer Discretionary
- SNN Health Care
- Exchange
- ALLE Nasdaq
- SNN Nasdaq
- Market Cap
- ALLE 10.6B
- SNN 11.4B
- IPO Year
- ALLE N/A
- SNN 1999
- Fundamental
- Price
- ALLE $141.86
- SNN $28.34
- Analyst Decision
- ALLE Hold
- SNN Hold
- Analyst Count
- ALLE 5
- SNN 3
- Target Price
- ALLE $140.40
- SNN $27.50
- AVG Volume (30 Days)
- ALLE 940.9K
- SNN 907.1K
- Earning Date
- ALLE 04-24-2025
- SNN 02-25-2025
- Dividend Yield
- ALLE 1.44%
- SNN 2.65%
- EPS Growth
- ALLE 16.19
- SNN 56.15
- EPS
- ALLE 7.12
- SNN 0.47
- Revenue
- ALLE $3,820,200,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- ALLE $4.34
- SNN $6.39
- Revenue Next Year
- ALLE $4.34
- SNN $5.11
- P/E Ratio
- ALLE $19.90
- SNN $30.19
- Revenue Growth
- ALLE 5.48
- SNN 4.70
- 52 Week Low
- ALLE $113.27
- SNN $23.65
- 52 Week High
- ALLE $156.10
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- ALLE 66.13
- SNN 60.87
- Support Level
- ALLE $139.11
- SNN $28.02
- Resistance Level
- ALLE $142.53
- SNN $28.53
- Average True Range (ATR)
- ALLE 2.62
- SNN 0.40
- MACD
- ALLE 0.72
- SNN 0.21
- Stochastic Oscillator
- ALLE 96.35
- SNN 77.08
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.